中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
5期
682-684
,共3页
中药%股骨头缺血性坏死%Meta分析
中藥%股骨頭缺血性壞死%Meta分析
중약%고골두결혈성배사%Meta분석
Herb%Avascular necrosis of formal head%Meta-analysis
目的 应用循证医学原理系统评价中医药治疗股骨头缺血性坏死的疗效和安全性.方法 检索1994-2010年中国全文期刊数据库、维普期刊数据库和万方数据库已发表的中医药治疗股骨头缺血性坏死临床试验的相关文献,采用Revman4.2软件进行统计分析.结果 共有11个随机对照试验1490例患者满足纳入条件,与对照组相比中药治疗股骨头缺血性坏死的有效率合并检验分析结果为:Z=2.89,P＜0.05,合并后的RR值为2.00,95％的可信区间为(1.25,3.19)；所有试验均未报道有明显不良反应.结论 中药治疗股骨头缺血性坏死具有较好的疗效和安全性.
目的 應用循證醫學原理繫統評價中醫藥治療股骨頭缺血性壞死的療效和安全性.方法 檢索1994-2010年中國全文期刊數據庫、維普期刊數據庫和萬方數據庫已髮錶的中醫藥治療股骨頭缺血性壞死臨床試驗的相關文獻,採用Revman4.2軟件進行統計分析.結果 共有11箇隨機對照試驗1490例患者滿足納入條件,與對照組相比中藥治療股骨頭缺血性壞死的有效率閤併檢驗分析結果為:Z=2.89,P＜0.05,閤併後的RR值為2.00,95％的可信區間為(1.25,3.19)；所有試驗均未報道有明顯不良反應.結論 中藥治療股骨頭缺血性壞死具有較好的療效和安全性.
목적 응용순증의학원리계통평개중의약치료고골두결혈성배사적료효화안전성.방법 검색1994-2010년중국전문기간수거고、유보기간수거고화만방수거고이발표적중의약치료고골두결혈성배사림상시험적상관문헌,채용Revman4.2연건진행통계분석.결과 공유11개수궤대조시험1490례환자만족납입조건,여대조조상비중약치료고골두결혈성배사적유효솔합병검험분석결과위:Z=2.89,P＜0.05,합병후적RR치위2.00,95％적가신구간위(1.25,3.19)；소유시험균미보도유명현불량반응.결론 중약치료고골두결혈성배사구유교호적료효화안전성.
Objective To evaluate the efficacy and safety of chinese mednine in treatment of avascular necrosis by evidence-based medicine principles.Methods Search 1994-2010 Chinese full-text periodical database,VIP Articles journal database and the Wanfang database have been published in the medical treatment of avascular necrosis of the clinical trial literature,Revman 4.2 software was used for statistical analysis.Results A total of 11 randomized controlled trials included 1490 cases of patients meet the criteria,compared with the control group of traditional Chinese medicine treatment of avascular necrosis of the efficiency test results of the analysis of the merger:Z =2.89,P ＜ 0.01,the combined RR of 2.00,95％ confidence interval(1.25,3.19); All trials were not reported significant adverse reactions.Conclusion Chinese medicine treatment of avascular necrosis had good efficacy and safety.
